Diagnósticos da América S.A. (BVMF:DASA3)

Market Cap	3.75B +74.4%
Revenue (ttm)	9.57B -38.0%
Net Income	-1.04B
EPS	n/a
Shares Out	1.25B
PE Ratio	n/a
Forward PE	15.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,228,100
Average Volume	1,845,555
Open	3.030
Previous Close	3.000
Day's Range	2.810 - 3.060
52-Week Range	1.180 - 4.770
Beta	0.37
RSI	43.69
Earnings Date	May 12, 2026

About Diagnósticos da América

Diagnósticos da América S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the CientíficaLab brand. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 17, 2000. The company was founded in 1966 and is ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1961
• Employees: 26,255
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DASA3

Financial Performance

In 2025, Diagnósticos da América's revenue was 11.17 billion, a decrease of -27.10% compared to the previous year's 15.32 billion. Losses were -1.15 billion, -3.92% less than in 2024.